Keywords
histological
liver
kidney
rat
Vitamin A
Abstract
Concor is a beta-blocker drug used to treat high blood pressure, acute coronary syndrome, and to control the rapid pulse of the heart such as atrial fibrillation. Some of its adverse effects include hepatitis, increased triglycerides and liver enzymes. Monitoring liver and kidney functions in patients with hepatic or renal impairment who are taking concor is recommended.
The current study was undertaken to define whether vitamin A could improve structural changes in the liver and kidneys. The 24 rats were grouped into the following. The first group was control. The second group was given Vitamin A (5000 IU). Group 3: given concor at a daily dose of 0.9 mg/kg B. wt. Group IV: received concor (0.9 mg/kg B. wt.) and Vitamin A (5000 IU) orally. After 4 weeks, the kidney of the treated group 3 exhibited degenerative alterations in the glomeruli, enlargement of Bowman’s space and the epithelium of the proximal kidney tubules showed vacuolar degeneration with necrosis. Liver sections showed degeneration and necrosis of hepatocytes, congestion of the central vein, dilation of sinusoids and inflammatory cell infiltration. Group 4 showed mild degeneration in the glomeruli, expansion of Bowman’s space and mild degeneration of tubular epithelium, and normal architecture of the liver with increased Kupffer cells. From this study, we concluded that concor drug induces structural changes in the liver and kidney and these effects were improved by Vitamin A administration.
References
1. Fikenzer S, Fikenzer K, Laufs U, Falz R, Schulze A, Busse M. Effects of cardioselective beta-blockade on plasma catecholamines and performance during different forms of exercise. J Sports Med Phys Fitness. 2020;60(4):643-9. Review match
2. Kazuo E, Satoshi H, Kazuomi K, Effects of celiprolol and bisoprolol on blood pressure, vascular stiffness, and baroreflex sensitivity. Am J Hypertens. 2015;28(7):858-67. Review match
3. Kishi T, Fujii E. Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications. Hypertens Res. 2019;42(4):496-503. Review match
4. Leopold G. Balanced pharmacokinetics and metabolism of bisoprolol. J Cardiovasc Pharmacol. 1986;8(Suppl 11):S16-20.
5. Konishi M, Haraguchi G, Kimura S, Inagaki H, Kawabata M, Hachiya H, et al. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure. Circ J. 2010;74(6):1127-34. Review match
6. Morales DR, Jackson C, Lipworth BJ, Donnan PT, Guthrie B. Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials. Chest. 2014;145(4):779-86. Review match
7. Carazo A, Macáková K, Matoušová K, Krčmová LK, Protti M, Mladěnka P. Vitamin A update: Forms, sources, kinetics, detection, function, deficiency, therapeutic use and toxicity. Nutrients. 2021; 13(5):1703. Review match
8. D'Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: an update. Nutrients. 2011;3(1):63-103.
9. Chen W, Chen G. The roles of Vitamin A in the regulation of carbohydrate, lipid, and protein metabolism. J Clin Med. 2014;3(2): 453-79.
10. Gudas LJ, Wagner JA. Retinoids regulate stem cell differentiation. J Cell Physiol. 2011;226(2):322-30.
11. Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr. 2001;21:167-92.
12. Mallipattu SK, He JC. The beneficial role of retinoids in glomerular disease. Front Med (Lausanne). 2015;2:16
13. Tilla W, Thomas B. Chapter 5.1 Handling and Restraint. In: Hans J Hedrich. The Laboratory Mouse (2nd edition). London: Academic Press; 2012:697-708. Review match
14. Zech P, Pozet N, Labeeuw M, Laville M, Hadj-Aissa A, Arkouche W, et al. Acute renal effects of beta-blockers. Am J Nephrol. 1986;6(Suppl 2): 15-9. Review match
15. Alsadek HB, Gamal S, Mohamed K, Walaa M. Adverse effects of bisoprolol in rats. Ady Pharmacol Clin Trials. 2019;4(3).
16. Téllez L, Ibáñez-Samaniego L, Pérez del Villar C, Yotti R, Martínez J, Carrión L, et al. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites. J Hepatol. 2020;73(6):1404-14. Review match
17. Hall ME, Rocco MV, Morgan TM, Hamilton CA, Jordan JH, Edwards MS, et al. Beta-blocker use is associated with higher renal tissue oxygenation in hypertensive patients suspected of renal artery stenosis. Cardiorenal Med. 2016;6(4):261-8. Review match
18. Bakris GL, Hart P, Ritz E. Beta blockers in the management of chronic kidney disease. Kidney Int. 2006;70(11):1905-13. Review match
19. Dumortier J, Guillaud O, Gouraud A, Pittau G, Vial T, Boillot O, et al. Atenolol hepatotoxicity: report of a complicated case. Ann Pharmacotherapy. 2009; 3(10):1719-23. Review match
20. Rua J, Prata AR, Marques R, Silva R, Gomes B, Fraga J, et al. Carvedilol-induced liver injury, a rare cause of mixed hepatitis: A clinical case. GE Port J Gastroenterol. 2019;26(3):196-201. Review match
21. Kleiner DE. Drug-induced liver injury: The hepatic pathologist's approach. Gastroenterol Clin North Am. 2017;46(2):273-96.
22. Mitchell NE, Harner W, Laczek J. β-Blocker-induced liver injury: A class effect with incidental rechallenge. ACG Case Rep J. 2019;6(11): e00273. Review match
23. Siva T, Girija S, Sankaran PK, Yuvaraj MF, Gayathri T, Lakshmi T, et al. Hepatoprotective effect of vitamin A and E on diclofenac induced hepatotoxicity in male Wistar albino rats. Int J Res Pharm Sci. 2019;10(3):1660-6.
24. Fisher K, Vuppalanchi R, Saxena R. Drug-induced liver injury. Arch Pathol Lab Med. 2015;139(7):876-87.
25. Bashandy S, Alhazza I. The Hepatoprotective effect of β-carotene against cadmium toxicity in rats. JPT. 2008;3:457-63.
26. Uboh FE, Ekaidem IS, Ebong PE, Umoh IB. The hepatoprotective effect of vitamin A against gasoline vapor toxicity in rats. Gastroenterology Res. 2009;2(3):162-7. Review match
27. Schafer F, Wang H, Kelley E, Cueno K, Buettner S. Comparing β-Carotene, vitamin E and nitric oxide as membrane. Antioxidants. 2002;383(3-4):671-81. Review match
28. Palace VP, Khaper N, Qin Q, Singal PK. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med. 1999;26(5-6):746-61. Review match
29. Sierra-Mondragon E, Rodríguez-Muñoz R, Namorado-Tonix C, Molina-Jijon E, Romero-Trejo D, Pedraza-Chaverri J, et al. All-trans retinoic acid attenuates fibrotic processes by downregulating TGF-β1/Smad3 in early diabetic nephropathy. Biomolecules. 2019;9(10):525. Review match
30. Wagner J, Dechow C, Morath C, Lehrke I, Amann K, Waldherr R, et al. Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol. 2000;11(8):1479-87.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2023 Authors